ng-nitroarginine methyl ester has been researched along with Breathlessness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brussino, L; Bucca, C; Mauro, M; Morello, M; Rolla, G; Scappaticci, E | 1 |
Fujimoto, I; Fukuda, A; Hida, H; Kumazaki, M; Nishino, H; Shimano, Y | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Breathlessness
Article | Year |
---|---|
Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome.
Topics: Administration, Inhalation; Dyspnea; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Hepatopulmonary Syndrome; Humans; Hypoxia; Liver Cirrhosis; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase | 2003 |
3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression.
Topics: Animals; Antihypertensive Agents; Astrocytes; Behavior, Animal; Cell Death; Dyspnea; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Guanidines; Immunohistochemistry; Immunosuppressive Agents; Injections, Subcutaneous; Male; Neostriatum; Neuritis; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitro Compounds; Propionates; Rats; Rats, Wistar; Tacrolimus | 1996 |